Clariane SE/€CLARI
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Clariane SE
Ticker
€CLARI
Sector
Primary listing
PAR
Industry
Health Care Providers & Services
Headquarters
Employees
61,798
ISIN
FR0010386334
Website
Clariane SE Metrics
BasicAdvanced
€1.9B
-
-€0.24
1.08
-
Price and volume
Market cap
€1.9B
Beta
1.08
52-week high
€5.51
52-week low
€1.49
Average daily volume
813K
Financial strength
Current ratio
0.564
Quick ratio
0.556
Long term debt to equity
163.82
Total debt to equity
198.533
Interest coverage (TTM)
1.00%
Profitability
EBITDA (TTM)
560.689
Gross margin (TTM)
31.99%
Net profit margin (TTM)
-1.04%
Operating margin (TTM)
5.68%
Effective tax rate (TTM)
25.90%
Revenue per employee (TTM)
€90,000
Management effectiveness
Return on assets (TTM)
1.27%
Return on equity (TTM)
-0.68%
Valuation
Price to revenue (TTM)
0.23
Price to book
0.5
Price to tangible book (TTM)
-0.98
Price to free cash flow (TTM)
2.056
Free cash flow yield (TTM)
48.64%
Free cash flow per share (TTM)
255.87%
Growth
Revenue change (TTM)
5.73%
Earnings per share change (TTM)
-75.95%
3-year revenue growth (CAGR)
8.48%
10-year revenue growth (CAGR)
9.04%
3-year earnings per share growth (CAGR)
-30.31%
10-year earnings per share growth (CAGR)
-11.07%
Bulls say / Bears say
Clariane SE reported a 6.6% organic revenue growth in 2024, reaching €5.28 billion, indicating strong operational performance across all business segments. (advfn.com)
The company successfully reduced its net financial debt by €409 million to €3.5 billion in 2024, demonstrating effective debt management and financial restructuring. (advfn.com)
Clariane's occupancy rates in elderly care facilities improved to over 90% by December 2024, reflecting increased demand and operational efficiency. (advfn.com)
Despite operational improvements, Clariane reported a net loss of €20 million pre-IFRS 16 in 2024, indicating ongoing profitability challenges. (advfn.com)
The company's loan-to-value ratio increased to 63% in 2024 from 58% the previous year, raising concerns about its financial leverage. (reuters.com)
Clariane's stock declined by 6.14% to €3.54 following the Q1 2025 revenue presentation, suggesting investor skepticism despite reported organic growth. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 2 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Clariane SE stock?
Clariane SE (CLARI) has a market cap of €1.9B as of July 03, 2025.
What is the P/E ratio for Clariane SE stock?
The price to earnings (P/E) ratio for Clariane SE (CLARI) stock is 0 as of July 03, 2025.
Does Clariane SE stock pay dividends?
No, Clariane SE (CLARI) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next Clariane SE dividend payment date?
Clariane SE (CLARI) stock does not pay dividends to its shareholders.
What is the beta indicator for Clariane SE?
Clariane SE (CLARI) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.